PUMA BIOTECHNOLOGY, INC. Warrants and Rights Outstanding
PUMA BIOTECHNOLOGY, INC. (PBYI) had Warrants and Rights Outstanding of $25.80 million as of 2012-12-31, per its 10-K filed 2014-03-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2014-03-03
- 2012-12-31: Warrants and Rights Outstanding $25.80M.
- 2012-09-30: Warrants and Rights Outstanding $13.80M.
- 2012-06-30: Warrants and Rights Outstanding $7.40M; Warrants and Rights Outstanding as first filed $7.37M.
- 2012-03-31: Warrants and Rights Outstanding $7.40M.
| Period end | Warrants and Rights Outstanding | Warrants and Rights Outstanding as first filed |
|---|---|---|
| 2012-12-31 | $25.80M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $13.80M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $7.40M 10-Q · filed 2013-08-06 | $7.37M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $7.40M 10-Q · filed 2013-05-09 | |
| 2011-12-31 | $7.60M 10-K · filed 2014-03-03 | |
| 2011-10-31 | $6.90M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |